Skip to content

Intra-Articular Ozone (O3) Injection Combined with Platelet-Rich Plasma (PRP) for Knee Meniscal Injury: A Randomized Controlled Trial

Intra-Articular Ozone (O3) Injection Combined with Platelet-Rich Plasma (PRP) for Knee Meniscal Injury: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121999
Enrollment
Unknown
Registered
2026-04-08
Start date
2026-04-15
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Meniscal Injury

Interventions

Intervention group:Intra-articular injection of ozone (O?) combined with platelet-rich plasma (PRP) into the knee joint, administered once every 3 weeks for a total of three injections, with an interv
Control group:Intra-articular injection of platelet-rich plasma (PRP) into the knee joint, administered once every 3 weeks for a total of three injections, with a total intervention period of 9 weeks.

Sponsors

Mianyang 404 Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Aged 40–85 years, with no restriction on sex; 2. Presence of knee pain, with no recent history of trauma; 3. MRI findings indicating Stoller grade I–IV lesions, consistent with a diagnosis of meniscal injury.

Exclusion criteria

Exclusion criteria: 1. Presence of systemic infection; 2. Hematologic disorders; 3. Malignancy, including confirmed or suspected cases; 4. Patients with poorly controlled diabetes mellitus; 5. Presence of other joint-related diseases, such as rheumatoid arthritis or acute gouty arthritis; 6. Patients who refuse intra-articular injection therapy.

Design outcomes

Primary

MeasureTime frame
Stoller grading assessed by MRI;

Secondary

MeasureTime frame
the Visual Analog Scale (VAS);Knee function (WOMAC score);Barthel Index (BI);

Countries

China

Contacts

Public ContactJihong Zhang

Affiliation of the Registrant:Mianyang 404 Hospital

15281141005@163.com+86 177 4431 5007

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026